›››
Loading...
Loading...
Strong VRP edge and calm realized vol support selling premium; flat Term Structure.
Edwards Lifesciences (EW) operates in the Health Care sector and has actively traded listed options. EW scores 77/100 for premium selling conditions. See Premium Selling for trade setup.
EW Edge Score: 77/100 — one of today's strongest setups for premium selling.
Consider Short Put at 39d to earnings.
Build Trade →Strong setup detected. Review the Short Put and build your trade.
Quantitative screening, not investment advice. Verify with your broker. Disclaimer
Edge Score = weighted composite of VRP, IV Rank, RV Regime, Earnings Proximity, Term Structure, and Liquidity. Ranges: Defensive (0–39), Selective (40–64), Favorable (65–100).IV Rank, VRP, RV Ratio, days to earnings, backwardation/contango, bid-ask spread quality
ORATS institutional options data, updated daily after market close (~6:00 PM ET)
The score reflects current market conditions and changes daily. A high score indicates favorable conditions for premium selling, not guaranteed profit. Always verify execution quality with your broker.
Edwards Lifesciences shows moderately favorable conditions for premium selling. Yang-Zhang realized volatility reads 35.4% over 20 days versus a 27.3% 60-day baseline. The RV Ratio (HV 20d / IV 30d) is 0.73, indicating calming conditions relative to implied expectations. A health care sector component tracked by volradar. For premium sellers tracking EW, this ratio suggests options are likely priced for more movement than the stock is currently delivering.
Over the past 18 trading days, EW's volatility has been dropping sharply. The RV ratio moved from a high of 1.57 down to the current 0.73 — a significant compression that often precedes favorable premium selling windows. During this period, 0 out of 18 days (0%) showed conditions favorable for sellers (ratio below 1.0). This kind of rapid vol compression in a health care name like EW typically means options haven't fully repriced lower yet — creating a temporary edge.
Based on current realized volatility, traders can expect EW to move approximately ±$1.73 (2.2%) per day and ±$3.87 (5.0%) over five trading days. At a stock price of $77.71, these ranges are derived from the Yang-Zhang volatility model which accounts for overnight gaps and intraday range — more accurate than simple close-to-close calculations. Premium sellers typically place short strikes outside these 1-standard-deviation ranges to achieve approximately 68%+ probability of profit.
Current conditions on EW point toward range-bound strategies like iron condor. Moderately calm conditions (ratio 0.73). Range-bound behavior favors iron condors. Iron Condor benefits from time decay while defining maximum risk on both sides — a structure that suits EW's current volatility profile where directional edge is limited but overall conditions are acceptable for premium collection.
VolRadar tracks EW daily as part of the S&P 500 universe, providing Yang-Zhang (OHLC-based) realized volatility across 10, 20, and 60-day windows, RV ratio analysis, expected move calculations, and premium selling condition assessments. Note: RV values on this page use the Yang-Zhang estimator (captures overnight gaps); VRP and RV Ratio use ORATS close-to-close RV to match the IV data source. Data is updated daily after market close (~6:00 PM ET). All analysis is for educational purposes only and does not constitute financial advice. Options trading involves significant risk of loss.
More about EW
Edwards Lifesciences currently shows strong premium selling conditions with an RV Ratio of 0.73. Realized volatility is below implied volatility, suggesting options may be overpriced relative to actual movement. Explore the Premium Selling page for detailed strategy recommendations and the Strategy Builder to model specific trades.
VolRadar tracks Edwards Lifesciences across 10 analysis dimensions updated daily after market close. The premium selling signal combines VRP edge, volatility regime, IV Rank, earnings proximity, and market-wide conditions into a single actionable verdict. Each sub-page goes deeper: VRP Analysis for the implied-vs-realized spread, IV Analysis for peer comparisons, Expected Move for strike placement, Earnings Crush for event history, and the Strategy Builder for modeling specific trades.
Edwards Lifesciences currently shows a strong premium selling signal with an RV Ratio of 0.73. Realized volatility is below implied volatility, suggesting options may be overpriced relative to actual price movement.
More analysis sections planned — Dark Pool Flow, Unusual Activity, Sector Comparison, and more.
Why two RV values? Yang-Zhang RV (35.4%, OHLC-based) captures intraday volatility, while ORATS RV (28.2%, close-to-close) uses only closing prices. For EW, YZ is higher — suggesting significant intraday movement not captured in closing prices. VRP is computed using ORATS RV to match the IV source. Gap: 7.2pp. Full IV Analysis →
Strong — Favorable (earnings-driven edge)
EM = Price × RV₂₀d × √(t/252). Uses Yang-Zhang 20d realized volatility (not implied). ±1σ (68% confidence).
Volatility smile & skew shifts
IV curve across expirations
Strategy
P&L calculator for any strategy
Ranked strategies & selling conditions
Best CC strikes, premiums & scores
CSP → assignment → CC calculator
Early assignment probability & alerts
Flow & Events
Support & resistance from OI
IV crush & historical earnings
Price range & strike placement
Historical expected move hit rates
Edwards Lifesciences's volatility is measured using two key metrics. The RV Ratio compares realized volatility (ORATS HV 20d) to implied volatility (IV 30d). When the RV Ratio drops below 0.85, realized movement is well below what options are pricing — the sweet spot for premium sellers. VRP (Volatility Risk Premium) measures the gap between IV and HV in percentage points — positive VRP means options are overpriced relative to actual movement. Current RV Ratio: 0.73.
Edwards Lifesciences's snapshot: IV Rank 46% (average premiums), VRP +10.2pp (options overpriced), RV Ratio 0.73 (calming volatility). These three metrics work together — IV Rank shows historical context, VRP shows current overpricing, and RV Ratio shows the volatility trend. See the IV Analysis page for peer comparisons and deeper breakdown.
VolRadar provides 10 analysis pages for Edwards Lifesciences: Overview (this page), Premium Selling (signal and strategy verdict), VRP Analysis (volatility risk premium history), Expected Move (range and probabilities), IV Analysis (implied volatility breakdown and peer comparison), Earnings Crush (historical post-earnings IV patterns), Options Strategy Builder (18 presets + custom calculator), Covered Call Analysis (ranked by CC Score), Wheel Strategy (CSP calculator and viability), and Support & Resistance Walls (options-derived price levels).
Every options trade carries risk: undefined-risk strategies (naked puts/calls) expose you to large losses on gap moves, while defined-risk strategies cap losses but reduce premium. For Edwards Lifesciences, current conditions favor premium sellers, but all options trades carry significant risk — always size positions so no single trade risks more than 1-3% of your account. Use the Strategy Builder to model worst-case scenarios before entering.
Edwards Lifesciences's Volatility Risk Premium (VRP) is +10.2pp, meaning implied volatility exceeds realized volatility by that amount. A positive VRP indicates options are overpriced relative to actual stock movement — this is the statistical edge premium sellers seek.
Based on Yang-Zhang realized volatility, Edwards Lifesciences has a 1-day expected move of ±$1.73 (±2.2%) and a 5-day expected move of ±$3.87 (±5.0%). This means the stock is expected to trade between $74 and $82 over the next week with approximately 68% probability.